Senior Device Engineer: Drug Delivery & Platform Lead

Gsk; Hertford Heath; Hybride; GBP 70 000 - 110 000; Plein temps

Résumé du poste

GSK is seeking a Principal Device Engineer to lead development and industrialisation of drug delivery devices at its Ware, Hertfordshire site in the UK. The role supports a hybrid working model with occasional travel and a focus on robust, patient-centric device platforms within a high-performing team.

The candidate will drive design controls, risk management and verification activities, contribute to global submissions, and collaborate across the GSK network to deliver late-stage portfolio

Qualifications

• Degree in Mechanical Engineering or Biomedical Engineering or related discipline.
• Experience with drug delivery devices and combination products (respiratory and/or parenteral).
• Familiarity with ISO 14971 and 13485 in design controls and risk management.

Responsabilités

• Provide technical leadership during development and industrialisation of drug delivery and combination product programmes.
• Collaborate with multi-disciplinary teams across GSK network and external partners.
• Work within design control framework to develop and execute work packages for platform-based DDF and RMFs.
• Contribute to authoring device parts of global submissions (e.g. technical file, BLA/MAA) and agency interactions.

Connaissances

Mechanical Engineering

Biomedical Engineering

Requirements management

Design controls

Risk management

Verification & validation

Project delivery

Leadership

Formation

Degree in Mechanical Engineering or Biomedical Engineering

Description du poste

GSK is seeking a Principal Device Engineer to lead development and industrialisation of drug delivery devices at its Ware, Hertfordshire site in the UK. The role supports a hybrid working model with occasional travel and a focus on robust, patient-centric device platforms within a high-performing team.

The candidate will drive design controls, risk management and verification activities, contribute to global submissions, and collaborate across the GSK network to deliver late-stage portfolio